Difference between revisions of "Part:BBa K3365059:Design"
(→Source) |
|||
Line 13: | Line 13: | ||
===Source=== | ===Source=== | ||
− | We get the sequence of homologous arm at both ends of <i>rpoZ</i> from reference and get the part of kanamycin resistant gene from | + | We get the sequence of homologous arm at both ends of <i>rpoZ</i> from reference and get the part of kanamycin resistant gene from pET28a contained kanamycin resistance through PCR. |
===References=== | ===References=== | ||
[1]David Bikard,Wenyan Jiang,Poulami Samai,Ann Hochschild,Feng Zhang,Luciano A. Marraffini1.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Research,2013,41(15):7429-7437. | [1]David Bikard,Wenyan Jiang,Poulami Samai,Ann Hochschild,Feng Zhang,Luciano A. Marraffini1.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Research,2013,41(15):7429-7437. |
Revision as of 11:42, 25 October 2020
kanamycin resistant gene with homologous arms
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
We choose additional antibiotic resistance genes that was not used before, kanamycin resistant gene as the alternatives to rpoZ, so that we can make a preliminary judgment with the medium containing kanamycin. Only the baterial which was knocked out rpoZ can survive in this medium while others cannot survive.
Source
We get the sequence of homologous arm at both ends of rpoZ from reference and get the part of kanamycin resistant gene from pET28a contained kanamycin resistance through PCR.
References
[1]David Bikard,Wenyan Jiang,Poulami Samai,Ann Hochschild,Feng Zhang,Luciano A. Marraffini1.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Research,2013,41(15):7429-7437.